repurposing semaglutide and liraglutide for alcohol use disorder GLP-1s Alcohol: How GLP-1s Reduce Consumption Medscape | Once weekly semaglutide

Semaglutide GLP-1 is a clinically proven treatment for obese patients with a BMI of 30 or greater or a BMI of at least 27 with comorbidities related to weight

But if you have been on semaglutide for eight or more weeks and are seeing minimal response, there are evidence-based adjustments worth considering before concluding the medication is not working

The SELECT trial was the first large, randomized study to show that a drug used for obesity could reduce cardiovascular disease, says Isaacs

The American Diabetes Association consistently recommends limiting sugar-sweetened beverages as a core dietary strategy for diabetes management

Avenell, A., Richmond, P

Liraglutide or placebo was administered daily, starting at 0.6 mg and increasing to 3.0 mg or the highest tolerated dose